ASCO 2017

The ASCO 2017 Annual Meeting in Chicago from June 2-6 is the world’s premier event for oncology. Last year, over 38,000 people attended; 37% of attendees were board certified in medical oncology and the most popular primary interest was in oncology studies in the clinic.   If you’re attending, let’s connect to say hello, learn […]

ASH 2016 Annual Meeting – Say Hello

It’s almost December, and that means it’s time for the ASH 2016 Annual Meeting. This is the world’s premier event in malignant & non-malignant hematology, and this year, it’s in sunny San Diego. The ASH 2016 Annual Meeting is a great way to network with top minds in the field, as well as a global community […]

Dr. Ron van Eijsden Joins Medelis, a Specialty Oncology CRO, as Managing Director, Medelis Europe

Nashville, TN – November 1, 2016 – Medelis, Inc., a specialty oncology CRO, today announced that Dr. Ron van Eijsden has joined Medelis as Managing Director, Medelis Europe. “Dr. Ron van Eijsden has a proven track record of leadership in the medical and clinical sections of the pharmaceutical, biotech and CRO industries,” said Bill Taaffe, […]

Specialty CROs, WCCT Global and Medelis, Announce Merger to Deliver Expanded Oncology and Clinical Research Services

CYPRESS, Calif., June 1, 2016 /PRNewswire/ — WCCT Global, an international specialized clinical research organization (CRO), and Medelis, Inc., a specialty oncology CRO, announced today that the companies have merged to offer US and international clients access to an expanded depth and breadth of clinical research offerings. “The complex and rapidly growing oncology drug development market […]

Guidelines for the Evaluation of Immune Therapy Activity

In a previous article, we discussed therapies that might affect the cancer-immunity cycle. Today’s article continues that discussion by reviewing the guidelines for the evaluation of immune therapy activity in solid tumors. These guidelines were published in 2009 in Clinical Cancer Research in Guidelines for the Evaluation of the Immune Therapy Activity in Solid Tumors: […]

Medelis Partners with The McGuire Institute to Continue Raising the Standards of Clinical Dentistry Research

Today, Medelis is proud to announce our partnership with The McGuire Institute to continue to advance the practice of dentistry through clinically-relevant practice-based research. Founded by Dr. Michael K. McGuire and Dr. E. Todd Scheyer, The McGuire Institute is a non-profit organization focused on delivering highly relevant clinical research that supports clients’ goals and advances the […]